JUL 28, 2026 · JOURNAL ARTICLE
Immune responses to ORF2-based vaccination and experimental porcine circovirus type 3 challenge in cesarean-derived, colostrum-deprived pigs 2309059
The Journal of Immunology
Small single-site controlled animal study with surrogate immunological endpoints and no clinical disease observed; provides mechanistic insight into PCV3 vaccine response but lacks power and clinical outcome data needed for efficacy claims.
Reported
Vaccine dose150 µg recombinant PCV3 ORF2 protein
Challenge dose133.33 µg PCV3
Group size6